MAMojgan Amrikachi

Mojgan Amrikachi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mojgan Amrikachi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Dina R. Mody

    From the Department of Pathology and Genomic Medicine, The Methodist Hospital, Weill Medical College of Cornell University, Houston, Texas

    3 shared publications
  • Aaron M. Harvey

    From the Department of Pathology and Genomic Medicine, The Methodist Hospital, Weill Medical College of Cornell University, Houston, Texas

    2 shared publications
  • Kirtee Raparia

    From the Department of Pathology, The Methodist Hospital, Houston, Texas (Drs Raparia, Mody, Anton, and Amrikachi); and Hallym University Sacred Heart Hospital, Anyang, Gyeonggi, South Korea (Dr Min)

    2 shared publications
  • Rose Anton

    From the Department of Pathology, The Methodist Hospital, Houston, Texas (Drs Raparia, Mody, Anton, and Amrikachi); and Hallym University Sacred Heart Hospital, Anyang, Gyeonggi, South Korea (Dr Min)

    2 shared publications
  • Soo Kee Min

    From the Department of Pathology, The Methodist Hospital, Houston, Texas (Drs Raparia, Mody, Anton, and Amrikachi); and Hallym University Sacred Heart Hospital, Anyang, Gyeonggi, South Korea (Dr Min)

    2 shared publications
  • Dina R Mody

    1 shared publication

Latest Publications

  • Thyroid Fine-Needle Aspiration Reporting Rates and Outcomes Before and After Bethesda Implementation Within a Combined Academic and Community Hospital System

    by Aaron M. Harvey, Dina R. Mody, Mojgan Amrikachi

    Context. —The current study compares data from our hospital system before and after the 2008 implementation of the Bethesda System for Reporting Thyroid Cytology (BSRTC). Objective. —To show the effects the BSRTC has had on the reporting rates and outcomes for thyroid lesions. Design. —A search for thyroid fine-needle aspiration biopsies (FNABs) was performed for 2002–2005 (before BSRTC) and 2009–2011 (after BSRTC). Diagnostic outcomes were reviewed for cases with available follow-up. Results. —For 2002–2005, cytology reports for 3302 thyroid FNABs were reviewed, and 309 (9.4%) were classified as suspicious. For 2009–2011, cytology reports for 3432 thyroid FNABs were reviewed; 72 (2.1%) were classified as “atypia of undetermined significance or follicular lesion of undetermined significance” (AUS/FLUS), and 142 (4.1%) were classified as suspicious. Follow-up material was available for 31 AUS/FLUS cases (43.0%), and 6 of these cases (19%) were malignant. Follow-up material was available for 60 cases (42.3%) classified as suspicious, and 23 of these cases (38%) were malignant. Conclusions. —The AUS/FLUS rate of 2.1% at our institution is at the lower range of the <7% recommended by the BSRTC, and our rate of 19% for risk of malignancy for AUS/FLUS is slightly above the BSRTC recommendation of 5% to 15%. Implementation of the BSRTC did not significantly affect our institution's reporting rates, most likely because an essentially similar classification system was employed before implementation of the BSRTC.


  • Disseminated blastomycosis diagnosed by fine‐needle aspiration of the thyroid

    by Aaron M. Harvey, Dina R. Mody, Mojgan Amrikachi

    Blastomycosis is an uncommon disease caused by the dimorphic fungus Blastomyces dermatitidis. It can manifest as chronic pulmonary symptoms or disseminated disease. Only three previous cases of blastomycosis involving the thyroid have been reported, of which two were diagnosed by fine‐needle aspiration. We present a case of disseminated blastomycosis initially diagnosed by thyroid fine‐needle aspiration. Our case was a 47‐year‐old man with past medical history significant for diabetes, hyperlipidemia, and chronic pancreatitis who presented with a 2‐week history of fever, chills, rigors, constipation, and 10 pound weight loss. Abdominal CT revealed chronic pancreatitis and a calcified mass in the pancreas. Chest CT revealed a single 1.5–2 cm thyroid mass and innumerably small 2‐3 mm pulmonary nodule bilaterally. Fine‐needle aspiration of the thyroid demonstrated 10–20 μm broad‐based budding yeasts with thick‐walled, refractile capsules amidst a background of granulomatous inflammation, and was diagnosed as a fungal infection consistent with blastomycosis. The patient was started on treatment with itraconazole based upon the FNA diagnosis. Concurrent lung biopsy demonstrated rare possible yeast forms on histology. A specimen from the lung was sent for culture, and was positive for B. dermatitidis, confirming the diagnosis. Disseminated blastomycosis rarely involves the thyroid. However, the thyroid is amenable to fine‐needle aspiration. Fungal and mycobacterial cultures and special stains for fungal organisms should be requested on all thyroid fine‐needle aspiration biopsies with granulomatous inflammation. Diagn. Cytopathol. 2011.


  • Clinical outcomes for "suspicious" category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy.

    by Kirtee Raparia, Soo Kee Min, Dina R Mody, Rose Anton, Mojgan Amrikachi

    Fine-needle aspiration (FNA) is recommended as an initial screening tool for the diagnosis of thyroid nodules. Approximately 10% of thyroid FNA diagnoses are "suspicious for neoplasm," warranting surgical resection. To examine the role of a patient's age, sex, size of nodule, and morphologic features as possible predictors of malignancy in patients with cytologic diagnosis of "suspicious for neoplasm." Cytopathology slides and reports of 402 consecutive thyroid FNAs from 2000-2005 interpreted as "suspicious" were reviewed. Of these, 180 cases that had subsequent surgical resection were selected. Of the 108 cases suspicious for follicular neoplasm on cytologic evaluation, histologic follow-up showed malignancy in 26 (24%). Of the 37 cases suspicious for Hürthle cell neoplasm, 15 (41%) had malignancy. Of the 35 cases suspicious for malignancy, 29 had malignant histologic diagnoses. Among cases with cytologic diagnoses of "suspicious for follicular or Hürthle cell neoplasm," the rate of malignancy in female patients was 22% as compared to 43% in male patients (P = .02). The rate of malignancy in nodules less than 2 cm was 19% compared to 47% in nodules measuring 2 cm or larger (P < .001). These differences were statistically significant. No statistically significant difference was noted between the age of the patient and the rate of benign versus malignant diagnosis. Malignant tumors were more frequent in male patients with a cytologic diagnosis of "suspicious for follicular or Hürthle cell neoplasm" than in female patients. Risk of malignancy was higher in nodules measuring 2 cm or larger. Age of the patient was not a predictor of malignancy.


  • Open Access

    Clinical Outcomes for “Suspicious” Category in Thyroid Fine-Needle Aspiration Biopsy: Patient's Sex and Nodule Size Are Possible Predictors of Malignancy

    by Kirtee Raparia, Soo Kee Min, Dina R. Mody, Rose Anton, Mojgan Amrikachi

    Context. —Fine-needle aspiration (FNA) is recommended as an initial screening tool for the diagnosis of thyroid nodules. Approximately 10% of thyroid FNA diagnoses are “suspicious for neoplasm,” warranting surgical resection. Objectives. —To examine the role of a patient's age, sex, size of nodule, and morphologic features as possible predictors of malignancy in patients with cytologic diagnosis of “suspicious for neoplasm.” Design. —Cytopathology slides and reports of 402 consecutive thyroid FNAs from 2000–2005 interpreted as “suspicious” were reviewed. Of these, 180 cases that had subsequent surgical resection were selected. Results. —Of the 108 cases suspicious for follicular neoplasm on cytologic evaluation, histologic follow-up showed malignancy in 26 (24%). Of the 37 cases suspicious for Hürthle cell neoplasm, 15 (41%) had malignancy. Of the 35 cases suspicious for malignancy, 29 had malignant histologic diagnoses. Among cases with cytologic diagnoses of “suspicious for follicular or Hürthle cell neoplasm,” the rate of malignancy in female patients was 22% as compared to 43% in male patients ( P = .02). The rate of malignancy in nodules less than 2 cm was 19% compared to 47% in nodules measuring 2 cm or larger ( P < .001). These differences were statistically significant. No statistically significant difference was noted between the age of the patient and the rate of benign versus malignant diagnosis. Conclusions. —Malignant tumors were more frequent in male patients with a cytologic diagnosis of “suspicious for follicular or Hürthle cell neoplasm” than in female patients. Risk of malignancy was higher in nodules measuring 2 cm or larger. Age of the patient was not a predictor of malignancy.